ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363

Recall map → All recalls → F-0463-2024

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. ActiPharma, Inc. · reported 2023-11-29

Terminated This recall has been closed out by the agency.

Reason for recall: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Classification: Class III
Recall initiated: 2023-09-28
Reported by the agency: 2023-11-29
Closed out (terminated): 2024-01-16
Recalling firm: ActiPharma, Inc.
Guaynabo, PR
United States
This is the firm that issued the recall — commonly a distributor or processor. It is not the origin of contamination.
Distribution (the agency's own words): Domestic distribution, in Puerto Rico.
States we parsed from that text: PR
The agency named these states. Parse method explicit_state_list, confidence high.
Food category: Dietary supplementsderived
Assigned by a reviewed keyword rulebook over the product description, not by the agency.
Recall type: Voluntary: Firm initiated
Recall number: F-0463-2024

This page reproduces a record published by the US Food and Drug Administration. It is not real-time: recalls typically appear in FDA's Enforcement Report weeks after they begin — a median of 40 days, see publication lag. For current food safety information consult FDA and USDA FSIS directly.